Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau

Recurrent ovarian cancer (OvCa) is thought to result in part from the inability to eliminate rare quiescent cancer stem cells (CSCs) that survive cytotoxic chemotherapy and drive tumor resurgence. The Sialyl-Thomsen-nouveau antigen (STn) is a carbohydrate moiety present on protein markers of CSCs in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Starbuck, Kristen, Al-Alem, Linah, Eavarone, David A., Hernandez, Silvia Fatima, Bellio, Chiara, Prendergast, Jillian M., Stein, Jenna, Dransfield, Daniel T., Zarrella, Bianca, Growdon, Whitfield B., Behrens, Jeff, Foster, Rosemary, Rueda, Bo R.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5955411/
https://ncbi.nlm.nih.gov/pubmed/29796189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25289
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados